Risks of Glutathione Any individual who has a sensitivity to sulfites is likely not a candidate for treatment as the GSH may lead to bronchoconstriction or trigger an asthma flare
A lot of them dont have the data. Toby wasnt here for a peptide injection, but Koniver advised him to try one on a future visit
8c, e, Supplementary Figs
Common dosing ranges from 600-1200 mg per dose, typically administered 1-3 times weekly for 4-8 weeks
Mechanistically, dampening the inflammatory chemicals that interfere with insulin signaling should improve how your cells respond to insulin
The specific gaps are: No human phase I or II trial for BPC-157 in any indication No published combination study in any model No pharmacokinetic data on subcutaneous GHK-Cu in humans No standardized outcome measures for the soft-tissue repair indications practitioners most commonly target The American College of Sports Medicine's 2023 position statement on peptide therapeutics in sports medicine did not endorse BPC-157 or GHK-Cu for any clinical use, citing insufficient human data
-1775582746855.png&w=3840&q=75)
